. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: Support Care Cancer. 2013 Feb 10;21(7):1827–1833. doi: 10.1007/s00520-013-1727-5

Table 3.

Ranking of top 10 drug classifications by group

Breast Cancer Survivors (n=98) n (%)	Midlife Women (n=138) n (%)

1. Multivitamin or vitamin 65 (66.3%)	1. Multivitamin or vitamin 76(55.1%)
2. Osteoporosis prevention 59(60.2%)	2. Dietary supplements 52(37.7%)
3. Dietary supplements 47 (48.0%)	3. Osteoporosis prevention 46(33.3%)
4. Antidepressants 37(37.8%)	4. Antihypertensive agent 38(27.5%)
5. Selective Estrogen Receptor Modulator 32(32.7%)	5. Antipyretics 37(26.8%)
6. Antipyretics 26(26.5%)	6. Antidepressants 34(24.6%)
7. Aromatase inhibitors 24(24.5%)	7. Antiulcer agent 25(18.1%)
8. Lipid lowering agent 17(17.3%)	8. Lipid lowering agent 21(15.2%)
9. Antihypertensive agent 16(16.3%)	9. Allergy/cold 20(14.5%)
10. Analgesics 15(15.3%)	10. Anti-angina 14(10.1%)
	10. Herbal 14(10.1%)